"
Skip to content
Topic:
Time-to-Event MAMS With Intermediate Outcomes
Simulating Intermediate-Outcome Selection Rules
Selection When Intermediate and Final Effects Disagree
Sensitivity Analysis for the Intermediate-Final Relationship
Separating Interim Timing From Intermediate Outcomes
Shared-Control Dependence in Intermediate Outcomes
Restricted Mean Survival Time at an Interim Landmark
Sample Size Planning With Intermediate Selection
Scheduling Looks for Intermediate Outcomes
Ranking Arms With Uncertain Intermediate Effects
Regression Prediction for Arm Selection
←
older
newer
→
Clinical Biostats